Fertility-sparing surgery for patients with low-grade endometrial stromal sarcoma

Weimin Xie; Dongyan Cao; Jiaxin Yang; Xuan Jiang; Keng Shen; Lingya Pan; Huifang Huang; Jinghe Lang; Yan You; Jie Chen

doi:10.18632/oncotarget.12491

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Clinical Research Papers:

Fertility-sparing surgery for patients with low-grade endometrial stromal sarcoma

Weimin Xie, Dongyan Cao, Jiaxin Yang _, Xuan Jiang, Keng Shen, Lingya Pan, Huifang Huang, Jinghe Lang, Yan You and Jie Chen

PDF | HTML | How to cite

Oncotarget. 2017; 8:10602-10608. https://doi.org/10.18632/oncotarget.12491

Metrics: PDF 1811 views | HTML 2391 views | ?

Abstract

Weimin Xie1, Dongyan Cao1, Jiaxin Yang1, Xuan Jiang1, Keng Shen1, Lingya Pan1, Huifang Huang1, Jinghe Lang1, Yan You2 and Jie Chen2

1 Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

2 Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Correspondence to:

Jiaxin Yang, email:

Keywords: fertility-sparing surgery, low-grade, endometrial stromal sarcoma , recurrence, pregnancy

Received: August 08, 2016 Accepted: September 29, 2016 Published: October 06, 2016

Abstract

Purpose: To assess the clinical outcomes and fertility of young women with stage I low-grade endometrial stromal sarcoma (ESS) treated with fertility-sparing surgery.

Results: Seventeen patients with stage I low-grade ESS (stage IA, n = 6; stage IB, n = 11) were entered into this study. Adjuvant hormone therapy was administered to 15 (88.2%) patients. At a median follow-up of 39 months (range, 4–106 months), 10 (58.8%) patients developed recurrence. All 10 patients had stage IB disease; among them, the first recurrence limited to the uterus was observed in 6 patients. All 17 patients were alive and disease-free at the time of last contact. After treatment, five of eight (62.5%) patients who attempted pregnancy conceived. No offspring had congenital anomalies.

Methods: Patients with stage I low-grade ESS who underwent fertility-sparing surgery between April 2001 and November 2015 were retrospectively reviewed.

Conclusions: Fertility-sparing surgery may be considered for young patients with stage IA low-grade ESS who wish to preserve their fertility.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 12491

Publication Alerts

Clinical Research Papers:

Fertility-sparing surgery for patients with low-grade endometrial stromal sarcoma

Abstract